Melatonin reduces IL‐33 and TSLP expression in human nasal epithelial cells by scavenging ROS directly
Immunity, Inflammation and Disease · 2023-02 · 11 (2)
DOI: 10.1002/iid3.788 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, online erschienen am 16.02.2023. Verfasst von Min-Jie Gong und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology Head and Neck Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Melatonin, Rhinitis, Nasal Polyps, Sinusitis. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Yulin City Science and Technology Plan Project, National Natural Science Foundation of China, Shaanxi Province Key R&D Program Projects.
Abstract (Originalsprache)
Background
Chronic rhinosinusitis (CRS) is a chronic mucosal inflammation of the nasal cavity and sinuses. It is classified into CRS without nasal polyps and CRS with nasal polyps (CRSwNP). CRSwNP has high recurrence, especially CRSwNP with massive eosinophil infiltration which is mediated by type 2 inflammatory response. Melatonin is a hormone secreted by the pineal gland, it has powerful antioxidant and anti‐inflammatory effects in addition to regulating biological rhythms. There are no studies on melatonin for the treatment of CRS, so we aimed to explore whether melatonin could be used for the treatment of CRS. Materials and Methods In this study, we used melatonin to treat a cell model of CRS. Subsequently, MTT assay was performed to examine the cell viability of human nasal epithelial cells (HNEpCs), a reactive oxygen species (ROS) kit to detect ROS production, a malondialdehyde (MDA) kit to detect the MDA content in the cell culture supernatant, and an apoptosis kit and Western blot analysis to detect apoptosis. The expressions of Nrf2, HO‐1, IL‐33, TSLP, and IL‐25 were detected by Western blot analysis.
Results
Melatonin improved the viability of HNEpCs, reduced lipopolysaccharide‐induced ROS, reduced the MDA content, and inhibited their apoptosis. More importantly, melatonin reduced the expression of IL‐33 and TSLP, an important phenomenon for the treatment of CRSwNP.
Conclusion
Melatonin protects HNEpCs from damage in inflammation and reduces IL‐33 and TSLP expression of HNEpCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology Head and Neck Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Oncology Research Lab, Key Laboratory of Environment and Genes Related to Diseases, Ministry of Education, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
ORCID-Profile: Ya Zhang
Förderung
- Yulin City Science and Technology Plan Project
- National Natural Science Foundation of China
- Shaanxi Province Key R&D Program Projects
Zitieren
APA
Gong, M. J., Zhang, H. B., Lou, M., Wang, Y. S., Ma, R. P., Hu, Z. Z., Zheng, G. X., & Zhang, Y. (2023). Melatonin reduces IL‐33 and TSLP expression in human nasal epithelial cells by scavenging ROS directly. Immunity, Inflammation and Disease, 11(2). https://doi.org/10.1002/iid3.788
Vancouver
Gong MJ, Zhang HB, Lou M, Wang YS, Ma RP, Hu ZZ, et al. Melatonin reduces IL‐33 and TSLP expression in human nasal epithelial cells by scavenging ROS directly. Immunity, Inflammation and Disease. 2023;11(2). doi:10.1002/iid3.788
BibTeX
@article{Gong2023,
author = {Gong, Min-Jie and Zhang, Hai-Bao and Lou, Miao and Wang, Yu-Sheng and Ma, Rui-Ping and Hu, Zhen-Zhen and Zheng, Guo-Xi and Zhang, Ya},
title = {Melatonin reduces IL‐33 and TSLP expression in human nasal epithelial cells by scavenging ROS directly},
journal = {Immunity, Inflammation and Disease},
year = {2023},
volume = {11},
number = {2},
doi = {10.1002/iid3.788}
}
EUVIMED